Patient Clinical Trials

See All Mercy Clinical Trials ›

Currently Displaying: Active Clinical Trials

Hide
Trial Status

747-302

Topic of Study: Gastrointestinal Disease
Sponsor: Intercept
Principal Investigator: Paul J. Thuluvath, M.D., FRCP, 410-332-9356
Research Coordinator: Olivia Tang, 410-843-2069
For More Information: otang@mdmercy.com
Coordinated Through: The Institute for Digestive Health and Liver Disease

This study is a phase 4 trial evaluating the effect of obeticholic acid on clinical outcomes in patients with primary biliary cholangitis. (302)

 

RECITE

Topic of Study: Gastrointestinal Disease
Sponsor: Amgen
Principal Investigator: Sandy Kotiah, M.D., 410-783-5858
Research Coordinator: Lisa McConnell, RN, 410-332-1200; Alexandra Cline, RN, 410-951-7956
Coordinated Through: Institutional Research

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal or Colorectal Cancer. (Clinicaltrials.gov ID#: NCT03362177)

AURORA

Topic of Study: Gastrointestinal Disease
Sponsor: Tobira Therapeutics
Principal Investigator: Paul Thuluvath, M.D., FRCP, 410-332-9356
Research Coordinator: Sung Cho, 410-576-5389
For More Information: scho@mdmercy.com
Coordinated Through: The Institute for Digestive Health and Liver Disease

This study is a phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of cenicriviroc for the treatment of liver fibrosis in adult subjects with nonalcoholic steatohepatitis. (AURORA)